Bis(phosphoramidate diester)-Based Ionizable Lipids for Highly Efficient Lung-Selective mRNA Delivery via Intercellular Transport
Nano Letters · 2026
DOI: 10.1021/acs.nanolett.6c02802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Huayu Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases and Jiangsu Key Laboratory of Drug Design …. Hauptthemen laut MEDLINE: RNA, Messenger, Lipids, Lung, Phosphoric Acids. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Highly efficient lung-selective mRNA delivery is pivotal for advancing mRNA-based targeted therapy. Here, we report bis(phosphoramidate diester)-based ionizable cationic lipids (bpLs) for lung-specific mRNA delivery via a distinct intercellular transport mechanism. A bpL library is synthesized by modular headgroups (Ha), linkers (Lb), and tails (Tc). In vivo screening identifies the formulated bpLH15L2T8/DOPENP as the top lung-selective lipid nanoparticle (LNP) with superior pulmonary mRNA transfection. We elucidate that mononuclear phagocyte-guided cell-to-cell trafficking of bpLH15L2T8/DOPENP contributes to its high efficiency and selectivity of mRNA expression in lung tissue. p53 mRNA (mp53) delivered by bpLH15L2T8/DOPENP restores p53 function in p53-deficient pulmonary metastases and synergizes with immune checkpoint inhibitors to enhance antitumor immunity and inhibit lung metastasis of triple-negative breast cancer (TNBC). An all-trans retinoic acid (ATRA) prodrug-containing bpLNP is further developed for lung-specific codelivery of ATRA and mp53, which effectively suppresses lung metastasis of cancer stem cell-enriched TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases and Jiangsu Key Laboratory of Drug Design and Optimization, Center of Advanced Pharmaceuticals and Biomaterials,…
ORCID-Profile: Yifei Huang, Ran Mo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Liu, H., Yang, B., Chen, S., Li, Y., Zhang, Y., Huang, Y., Xing, J., Liu, H., Jiang, S., & Mo, R. (2026). Bis(phosphoramidate diester)-Based Ionizable Lipids for Highly Efficient Lung-Selective mRNA Delivery via Intercellular Transport. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02802
Vancouver
Liu H, Yang B, Chen S, Li Y, Zhang Y, Huang Y, et al. Bis(phosphoramidate diester)-Based Ionizable Lipids for Highly Efficient Lung-Selective mRNA Delivery via Intercellular Transport. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02802
BibTeX
@article{Liu2026,
author = {Liu, Huayu and Yang, Bowen and Chen, Shuye and Li, Yikun and Zhang, Ying and Huang, Yifei and Xing, Jiaqi and Liu, Hao and Jiang, Sida and Mo, Ran},
title = {Bis(phosphoramidate diester)-Based Ionizable Lipids for Highly Efficient Lung-Selective mRNA Delivery via Intercellular Transport},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.6c02802}
}
EUVIMED